ANI Pharmaceuticals Announces Launch of Diphenoxylate HCl and Atropine Sulfate Tablets

BAUDETTE, Minn., June 20, 2017 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the launch of Diphenoxylate HCl and Atropine Sulfate Tablets, 2.5mg/0.025mg. The annual U.S. market for... Biopharmaceuticals, Generics, Product Launch ANI Pharmaceuticals, Diphenoxylate, Atropine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news